Cargando…
How the Structure of Per- and Polyfluoroalkyl Substances (PFAS) Influences Their Binding Potency to the Peroxisome Proliferator-Activated and Thyroid Hormone Receptors—An In Silico Screening Study
In this study, we investigated PFAS (per- and polyfluoroalkyl substances) binding potencies to nuclear hormone receptors (NHRs): peroxisome proliferator-activated receptors (PPARs) α, β, and γ and thyroid hormone receptors (TRs) α and β. We have simulated the docking scores of 43 perfluoroalkyl comp...
Autores principales: | Kowalska, Dominika, Sosnowska, Anita, Bulawska, Natalia, Stępnik, Maciej, Besselink, Harrie, Behnisch, Peter, Puzyn, Tomasz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866891/ https://www.ncbi.nlm.nih.gov/pubmed/36677537 http://dx.doi.org/10.3390/molecules28020479 |
Ejemplares similares
-
Consideration of pathways for immunotoxicity of per- and polyfluoroalkyl substances (PFAS)
por: Ehrlich, Veronika, et al.
Publicado: (2023) -
Internal Relative Potency Factors for the Risk Assessment of Mixtures of Per- and Polyfluoroalkyl Substances (PFAS) in Human Biomonitoring
por: Bil, Wieneke, et al.
Publicado: (2022) -
Managing and treating per- and polyfluoroalkyl substances (PFAS) in membrane concentrates
por: Tow, Emily W., et al.
Publicado: (2021) -
Per- and polyfluoroalkyl substances (PFAS) exposure and thyroid cancer risk
por: van Gerwen, Maaike, et al.
Publicado: (2023) -
Comment on “Internal Relative Potency Factors for the Risk Assessment of Mixtures of Per- and Polyfluoroalkyl Substances (PFAS) in Human Biomonitoring”
por: Andra, Syam S., et al.
Publicado: (2022)